![]() |
市场调查报告书
商品编码
1734816
2032 年内视镜封闭系统市场预测:按产品类型、应用、最终用户和地区进行的全球分析Endoscopic Closure Systems Market Forecasts to 2032 - Global Analysis By Product Type (Clips, Endoscopic Suturing Systems, Endoscopic Banding Devices and Other Product Types), Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球内视镜闭合系统市场预计在 2025 年达到 6.117 亿美元,到 2032 年达到 10.483 亿美元,预测期内的复合年增长率为 8%。
内视镜闭合系统是一种在微创手术过程中用于闭合内部组织切口或开口的医疗设备。这些系统通常由缝线、钉书钉和夹子组成,透过内视镜传送以实现闭合,而无需进行大切口。与传统的开放性手术相比,它通常用于胃肠道、减肥和外科手术,以促进癒合、减少併发症并缩短患者的康復时间。
根据美国胃肠内视镜学会 (ASGE) 的数据,光是在美国,每年就进行约 2,000 万例内视镜检查。
胃肠道疾病增多
胃肠道(GI)疾病盛行率的不断上升是内视镜封闭系统市场发展的主要驱动力。随着全球大肠直肠癌、发炎性肠道疾病疾病和消化性溃疡等疾病负担的增加,对侵入性更小、恢復更快的先进外科手术干预的需求日益增长。内视镜闭合系统在封闭内部伤口和预防併发症、改善患者预后和缩短住院时间方面发挥关键作用。随着对微创解决方案的需求增加,预计这一趋势将在未来持续下去,从而进一步推动市场成长。
熟练内视镜医师短缺
整合如此先进的设备需要专门的培训和专业知识,而并非所有医疗保健机构都具备这些培训和专业知识,尤其是在新兴国家。此外,培训计划的高成本和复杂性可能会阻碍医疗保健提供者采用这些技术。因此,缺乏经过充分培训的专业人员限制了内视镜闭合系统的广泛应用,阻碍了市场扩张并限制了患者获得这些先进疗法的机会。
全球老年人口不断成长
老年人更容易患慢性疾病,包括胃肠道疾病,并且通常需要手术干预。由于恢復时间更快、併发症风险更低,老年族群更倾向于微创手术,这推动了对内视镜闭合系统的需求。这种人口结构变化,加上医疗基础设施的进步和医疗支出的增加,预计将显着推动已开发市场和新兴市场的市场成长。
手术相关併发症的风险
儘管内视镜闭合手术有其优点,但它也存在固有的风险,包括感染、设备移位和术后併发症。这些风险可能会危及病人安全并导致额外的干预,增加医疗成本并阻碍此类系统的采用。此外,对一次性设备医疗废弃物的担忧以及对更强大、更可靠的封闭解决方案的需求进一步使市场动态复杂化。
由于选择性手术延迟和医院就诊人数减少,COVID-19 疫情最初扰乱了内视镜闭合系统市场。随着医疗资源转向对抗疫情,内视镜手术暂时减少。然而,随着限制的放宽和医疗保健系统的适应,对微创手术的需求已经恢復。疫情也加速了远端医疗和远端监控的采用,透过促进患者管理和内视镜手术的后续治疗,间接地支持了市场。
止血(出血控制)领域预计将成为预测期内最大的市场
预计在预测期内,止血(控制出血)部分将占据最大的市场占有率。这项优点源自于内视镜检查过程中对有效控制出血的迫切需求,特别是在涉及消化性溃疡、静脉曲张出血和息肉切除术后介入的情况下。内视镜止血夹等止血装置可立即可靠地控制出血,降低併发症的风险并减少采用更具侵入性的手术方法的需要。全球范围内胃肠道疾病的发病率不断上升以及内视镜手术的增加进一步巩固了该主导市场地位。
预计预测期内门诊手术中心 (ASC) 部分将以最高的复合年增长率成长。
预计门诊手术中心 (ASC) 部门将在预测期内见证最高的成长率。这种快速扩张的原因是人们对门诊病人和具有成本效益的手术程序的偏好日益增长,因为与传统医院环境相比,ASC 可以缩短住院时间、降低感染风险并降低医疗成本。 ASC 采用微创技术,加上内视镜闭合技术的进步,使得这些中心成为患者和医疗保健提供者的首选。
预计北美地区将在预测期内占据最大的市场占有率。这项优势由多种因素推动,包括高昂的医疗费用、早期采用先进的医疗技术以及完善的医疗保健基础设施。此外,该地区拥有大量经验丰富的内视镜医师和主要市场参与企业,可以快速采用创新的封闭系统。此外,优惠的报销政策和胃肠道疾病的高盛行率也促成了该地区较大的市场占有率。
预计亚太地区在预测期内的复合年增长率最高。这一显着增长可归因于医疗保健投资的增加、人们对微创手术的认识的提高以及老年人口的增加。此外,胃肠道疾病的快速增长和政府为提高医疗保健可及性而采取的倡议正在加速中国和印度等国家采用先进的内视镜技术。该地区医疗保健基础设施的扩大和具有成本效益的解决方案的进入预计将进一步推动强劲的市场成长。
According to Stratistics MRC, the Global Endoscopic Closure Systems Market is accounted for $611.7 million in 2025 and is expected to reach $1048.3 million by 2032 growing at a CAGR of 8% during the forecast period. Endoscopic closure systems are medical devices used to close incisions or openings in internal tissues during minimally invasive procedures. These systems typically consist of sutures, staples, or clips delivered through an endoscope to achieve closure without the need for large incisions. They are commonly used in gastrointestinal, bariatric, and surgical applications to promote healing, reduce complications, and improve patient recovery time compared to traditional open surgery methods.
According to the American Society for Gastrointestinal Endoscopy (ASGE), approximately 20 million endoscopic procedures are performed annually in the United States alone.
Rising incidence of gastrointestinal (GI) disorders
The growing prevalence of gastrointestinal (GI) disorders is a significant driver for the endoscopic closure systems market. As the global burden of conditions such as colorectal cancer, inflammatory bowel disease, and peptic ulcers rises, there is an increasing need for advanced surgical interventions that are less invasive and offer faster recovery. Endoscopic closure systems play a crucial role in sealing internal wounds and preventing complications during these procedures, which enhances patient outcomes and reduces hospital stays. This trend is expected to continue, further fueling market growth as the demand for minimally invasive solutions escalates.
Limited skilled endoscopists
The integration of these sophisticated devices requires specialized training and expertise, which are not uniformly available across all healthcare settings, particularly in emerging economies. Additionally, the high cost and complexity of training programs can deter healthcare providers from adopting these technologies. As a result, the lack of adequately trained professionals restricts the broader adoption of endoscopic closure systems, thereby impeding market expansion and limiting patient access to these advanced treatments.
Rising geriatric population globally
Older adults are more susceptible to chronic diseases, including GI disorders, which often require surgical intervention. The preference for minimally invasive procedures among elderly patients-due to reduced recovery times and lower complication risks-drives demand for endoscopic closure systems. This demographic shift, coupled with advancements in healthcare infrastructure and increased healthcare spending, is expected to significantly boost market growth in both developed and developing regions.
Risk of procedure-related complications
Despite their benefits, endoscopic closure procedures carry inherent risks, such as infection, device migration, and post-procedural complications. These risks can undermine patient safety and lead to additional interventions, increasing healthcare costs and potentially deterring the adoption of such systems. Moreover, concerns over medical waste from disposable devices and the need for more robust, reliable closure solutions further complicate market dynamics.
The Covid-19 pandemic initially disrupted the endoscopic closure systems market due to the postponement of elective surgeries and reduced hospital visits. Healthcare resources were redirected to manage the pandemic, leading to a temporary decline in endoscopic procedures. However, as restrictions eased and healthcare systems adapted, there was a resurgence in demand for minimally invasive treatments. The pandemic also accelerated the adoption of telemedicine and remote monitoring, which indirectly supported the market by facilitating patient management and follow-up care for endoscopic interventions.
The hemostasis (Management of Bleeding) segment is expected to be the largest during the forecast period
The hemostasis (Management of Bleeding) segment is expected to account for the largest market share during the forecast period. This dominance is attributed to the critical need for effective bleeding control during endoscopic procedures, particularly in cases involving peptic ulcers, variceal bleeding, and post-polypectomy interventions. Hemostasis devices, such as endoscopic hemoclips, provide immediate and reliable control of bleeding, reducing the risk of complications and the need for more invasive surgical approaches. The increasing prevalence of GI disorders and the growing number of endoscopic procedures globally further reinforce the segment's leading position in the market.
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate. This rapid expansion is driven by the increasing preference for outpatient and cost-effective surgical procedures, as ASCs offer shorter hospital stays, lower infection risks, and reduced healthcare costs compared to traditional hospital settings. The adoption of minimally invasive techniques in ASCs, coupled with advancements in endoscopic closure technologies, is making these centers a preferred choice for both patients and healthcare providers.
During the forecast period, the North America region is expected to hold the largest market share. This dominance is underpinned by several factors, including high healthcare expenditure, early adoption of advanced medical technologies, and a well-established healthcare infrastructure. The region also benefits from a large base of skilled endoscopists and a strong presence of major market players, which facilitates the rapid uptake of innovative closure systems. Additionally, favorable reimbursement policies and a high prevalence of GI disorders contribute to the region's substantial market share.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is fueled by rising healthcare investments, increasing awareness of minimally invasive procedures, and a growing geriatric population. Furthermore, the surge in GI disorders and government initiatives to enhance healthcare access are accelerating the adoption of advanced endoscopic technologies across countries like China and India. The region's expanding healthcare infrastructure and the entry of cost-effective solutions are expected to further drive robust market growth.
Key players in the market
Some of the key players in Endoscopic Closure Systems Market include CooperSurgical Inc., Abbott Laboratories, Apollo Endosurgery Inc., Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, Duomed Group, ENDO-FLEX GmbH, EnVision Endoscopy, Johnson & Johnson Services Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., Micro-Tech USA Incorporated, Olympus Corporation, Ovesco Endoscopy AG, Steris plc, US Endoscopy and B. Braun Melsungen AG.
In April 2025, Abbott Laboratories showcased the Perclose(TM) ProStyle(TM) Suture-Mediated Closure and Repair System at HRS 2025.
In April 2025, Medtronic plc announced a distribution agreement with Dragonfly(TM) Endoscopy for pancreaticobiliary endoscopic closure solutions.
In April 2025, Boston Scientific Corporation introduced the MANTIS(TM) Clip and X-Tack(TM) Endoscopic HeliX Tacking System.